The Latest Breaking News from Sanofi

Only recently, activists, public health experts, tuberculosis (TB) survivors, and people living with HIV had sought Prime Minister Narendra Modi’s intervention to halt what they said were frequent shortages in the availability of anti-TB drugs.

Sanofi will settle around 4,000 claims alleging its heartburn medication, Zantac, is linked to cancer.

Since the 1970s, it has been known that sodium valproate can harm babies in the womb. So why was it prescribed to pregnant women?

The pharma industry is poised for robust expansion this year with rising demand and technological advancement in the sector. Hence, investors might watch fundamentally solid pharma stocks Procaps Group (PROC), Sanofi (SNY), Viatris (VTRS), Ipsen (IPSEY), and Teva Pharmaceutical Industries (TEVA) for solid gains. Read on.

The pharmaceutical industry, which experienced significant growth over the past years, is anticipated to remain buoyed, driven by the increasing prevalence of chronic diseases, advancements in medical technology, and rising healthcare awareness and expenditure. Given this backdrop, quality pharma stocks Voyager Therapeutics (VYGR), Sanofi (SNY), and Pacira BioSciences (PCRX), with…

Sanofi stock undercut its 50-day line Thursday despite Dupixent outperformance as its earnings lagged Wall Street's expectations.

Sanofi is getting into the liver disease treatment space with its $1.7 billion acquisition of biotech stock Inhibrx. But Sanofi stock toppled.

There's a revolution in immunology that could completely shift a paradigm biotech stocks. And Big Pharma is paying billions to get in.

Sanofi is hoping the exposure will help put the brand in front of prospective young talent which it has struggled to recruit.